Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
15.67
0.00 (0.00%)
At close: Jul 8, 2026, 4:00 PM EDT
15.64
-0.03 (-0.19%)
After-hours: Jul 8, 2026, 6:14 PM EDT
Rallybio Market Cap
Rallybio has a market cap or net worth of $83.02 million as of July 8, 2026. Its market cap has increased by 539.64% in one year.
Market Cap
83.02M
Enterprise Value
36.54M
1-Year Change
539.64%
Ranking
Category
Stock Price
$15.67
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $83.02M, a decrease of -79.53%. That is a compound annual growth rate of -27.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 83.02M | 186.45% |
| Dec 31, 2025 | 28.98M | -27.23% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | 405.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MAIA Biotechnology | 87.25M |
| Cardiff Oncology | 87.17M |
| Pelthos Therapeutics | 86.37M |
| Rani Therapeutics Holdings | 85.39M |
| Telomir Pharmaceuticals | 84.69M |
| Acrivon Therapeutics | 83.46M |
| Gossamer Bio | 82.71M |
| Heron Therapeutics | 82.56M |